Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

The Dosage of Pten Is Critical in Determining the Disease Severity - a Mouse Model Differentially Mimicking JMML and CMML

Yan Yan, MD, Natalia C Colorado, MD, Shelly Lensing, MS, Delli R Robinson, Nicholas J Baltz, Daohong Zhou, MD, Peter Dean Emanuel, MD, Y. Lucy Liu, MD PhD

Blood (2016) 128 (22): 1550.

https://doi.org/10.1182/blood.V128.22.1550.1550

Published: 2016

Journal Articles

JQ1, a Potential Therapeutic Molecule for Myeloid Leukemia with PTEN Deficiency

Nicholas J Baltz, Natalia C Colorado, MD, Yan Yan, MD, Shelly Lensing, MS, Delli Robinson, BA, Michele H. Cottler-Fox, MD, Jason E Farrar, MD, Peter Dean Emanuel, MD, Y. Lucy Liu, MD PhD

Blood (2016) 128 (22): 5899.

https://doi.org/10.1182/blood.V128.22.5899.5899

Published: 2016

Journal Articles

Timing of the Loss of Pten Is Critical in Determining the Disease Phenotype in Mice- a Mouse Model for Pediatric Mixed MDS/MPN

Y. Lucy Liu, MD PhD, Yan Yan, MD, Cody Webster, BS, Lijian Shao, MD PhD, Shelly Y. Lensing, MS, Hongyu Ni, MD PhD, Wei Feng, MD, Daohong Zhou, MD, Zhifu Xiang, MD, Natalia Colorado, MD, Delli Robinson, Shaoguang Li, MD PhD, Peter D Emanuel, MD

Blood (2014) 124 (21): 3585.

https://doi.org/10.1182/blood.V124.21.3585.3585

Published: 2014

Journal Articles

Overexpression Of DNMT3a and DNMT3b Is Related To Downregulation Of Mir-29a In Juvenile Myelomonocytic Leukemia (JMML)

Y. Lucy Liu, MD, PhD, Shelly Y. Lensing, MS, Yan Yan, MD, Cody Webster, BS, Peter D. Emanuel, MD

Blood (2013) 122 (21): 4890.

https://doi.org/10.1182/blood.V122.21.4890.4890

Published: 2013

Journal Articles

Mir-183 Over-Expression: A Potential Biomarker for Juvenile Myelomonocytic Leukemia (JMML).

Y. Lucy Liu, MD, PhD, Yan Yan, MD, Shelly Y. Lensing, MS, Todd Cooper, DO, Peter D. Emanuel, MD

Blood (2012) 120 (21): 2558.

https://doi.org/10.1182/blood.V120.21.2558.2558

Published: 2012

Journal Articles

Novel Model of Stimulation-Responsive Splicing for Generation of Immunogenic Isoforms of Tumor Antigens and Autoantigens.

Fan Yang, MD, PhD, Yan Yan, MD, PhD, Zeyu Xiong, MD, Irene H. Chen, MD, Hong Wang, MD, PhD, Xiao-Feng Yang, MD, PhD

Blood (2006) 108 (11): 5188.

https://doi.org/10.1182/blood.V108.11.5188.5188

Published: 2006

Journal Articles

A Novel Mechanism in Generation of Self-Antigen Repertoire - An Unconventional Antigen Translated by a Novel Internal Ribosome Entry Site Elicits Anti-Tumor Humoral Immune Responses.

Xiao-Feng Yang, MD, PhD, Zeyu Xiong, MD, Enli Liu, MD, Yan Yan, MD, PhD, Richard T. Silver, MD, Srdan Verstovsek, MD, PhD, Josef Prchal, MD, Hong Wang, MD, PhD

Blood (2006) 108 (11): 3702.

https://doi.org/10.1182/blood.V108.11.3702.3702

Published: 2006

Journal Articles

Novel Unconventional Antigen and Conventional Antigens Elicit Anti-Tumor Humoral Immune Reactions in Response to Interferon-a Therapy.

Xiao-Feng Yang, MD, PhD, Zeyu Xiong, MD, Enli Liu, MD, Yan Yan, MD, PhD, Yu Yang, MD, PhD, Srdan Verstovsek, MD, PhD, Josef Prchal, MD, Hong Wang, MD, PhD

Blood (2004) 104 (11): 2432.

https://doi.org/10.1182/blood.V104.11.2432.2432

Published: 2004

NARROW

The Dosage of Pten Is Critical in Determining the Disease Severity - a Mouse Model Differentially Mimicking JMML and CMML

JQ1, a Potential Therapeutic Molecule for Myeloid Leukemia with PTEN Deficiency

Timing of the Loss of Pten Is Critical in Determining the Disease Phenotype in Mice- a Mouse Model for Pediatric Mixed MDS/MPN

Overexpression Of DNMT3a and DNMT3b Is Related To Downregulation Of Mir-29a In Juvenile Myelomonocytic Leukemia (JMML)

Mir-183 Over-Expression: A Potential Biomarker for Juvenile Myelomonocytic Leukemia (JMML).

Novel Model of Stimulation-Responsive Splicing for Generation of Immunogenic Isoforms of Tumor Antigens and Autoantigens.

A Novel Mechanism in Generation of Self-Antigen Repertoire - An Unconventional Antigen Translated by a Novel Internal Ribosome Entry Site Elicits Anti-Tumor Humoral Immune Responses.

Novel Unconventional Antigen and Conventional Antigens Elicit Anti-Tumor Humoral Immune Reactions in Response to Interferon-a Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only